Sector portfolio · VC firm · United States

New Enterprise Associates' Biotech portfolio

New Enterprise Associates has backed 104 Biotech startups in rounds we track, $16B between them, shown by the stage each has reached. The best-funded is Intarcia Therapeutics.

104startups backed
6stages
$16Braised between them
Series C and laterbiggest stage

New Enterprise Associates's whole portfolioNew Enterprise Associates's profile

Series C and later

31

+7 more

Stage not reported

25

+1 more

Series B

22

Series A

22

Growth

2

Pre-seed and seed

2

Segment by segment

Series C and later

31 startups · $5.2B raised

  1. BHBright HealthUnited States$1.1B
  2. 23andMeUnited States$729M
  3. Trevi TherapeuticsTrevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.United States$386M
  4. CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M
  5. SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M
  6. WelltokSilverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement.United States$239M
  7. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
  8. DDermiraDermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.United States$169M

Stage not reported

25 startups · $4.0B raised

  1. Mirum PharmaceuticalsMirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.United States$669M
  2. Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530M
  3. EpizymeEpizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.United States$332M
  4. Monte Rosa TherapeuticsMonte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.Switzerland$300M
  5. Pionyr ImmunotherapeuticsPionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.-$275M
  6. EarLensEarlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.United States$248M
  7. Nkarta TherapeuticsNkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.United States$240M
  8. X4 PharmaceuticalsX4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.United States$193M

Series B

22 startups · $3.5B raised

  1. Gossamer BioGossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.United States$567M
  2. ArcellxArcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.United States$285M
  3. Cardurion PharmaceuticalsCardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeuticsUnited States$260M
  4. Shape TherapeuticsA biotechnology company developing RNA technologies to shape the future of gene therapyUnited States$260M
  5. Galera TherapeuticsGalera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.United States$219M
  6. Annexon BiosciencesAnnexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.United States$180M
  7. Tune TherapeuticsTune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020.United States$175M
  8. FIRE1FIRE1, officially known as The Foundry Innovation and Research 1, Ltd., is a connected medical device company based in Dublin, Ireland.Ireland$170M

Series A

22 startups · $2.5B raised

  1. CelcuityCelcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.United States$1.0B
  2. Rhythm PharmaceuticalsRhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeuticsUnited States$311M
  3. Ouro MedicinesOuro Medicines is a biotechnology company based in South San Francisco, established in 2025 by Monograph Capital in partnership with GSK.United States$120M
  4. Nexo TherapeuticsNexo Therapeutics is a biotechnology company dedicated to discovering and developing small-molecule therapies, particularly in oncUnited States$120M
  5. IPInozyme PharmaUnited States$116M
  6. RPReneo PharmaceuticalsReneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.United States$105M
  7. Satsuma PharmaceuticalsSatsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.United States$92M
  8. Code BiotherapeuticsCode Biotherapeutics (Code Bio) is a biotechnology company founded in 2020, based in Hatfield, Pennsylvania.United States$75M

Growth

2 startups · $1.1B raised

  1. Intarcia TherapeuticsIntarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.United States$1.1B
  2. American Pathology PartnersAP2 is a provider of anatomic pathology and related specialized testing services.United States$6.0M

Pre-seed and seed

2 startups · $46M raised

  1. RRhythmUnited States$42M
  2. CurisiumInnovative Healthcare ContractingUnited States$3.5M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names New Enterprise Associates as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioNew Enterprise Associates' AI portfolio108 startups · $50BSector portfolioNew Enterprise Associates' Big Data & Analytics portfolio39 startups · $2.6BSector portfolioNew Enterprise Associates' Fintech portfolio38 startups · $8.9BSector portfolioNew Enterprise Associates' IT Services portfolio38 startups · $4.3BSector portfolioNew Enterprise Associates' Internet portfolio32 startups · $4.1BSector portfolioNew Enterprise Associates' Software portfolio29 startups · $1.1B

Raising from investors like New Enterprise Associates?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps